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Abstract
Background: Ubiquitinated-protein aggregates are implicated in cerebral ischemia/reperfusion injury. The very
presence of these ubiquitinated-protein aggregates is abnormal and seems to be disease-related. However, it is not
clear what leads to aggregate formation and whether the aggregations represent a reaction to aggregate-mediated
neurodegeneration.
Methods: To study the nitrosative stress-induced protein aggregation in cerebral ischemia/reperfusion injury, we
used primary astrocyte cultures as a cell model, and systematically examined their iNOS expression and consequent
NO generation following oxygen glucose deprivation and reperfusion. The expression of protein disulfide isomerase
(PDI) and copper-zinc superoxide dismutase (SOD1) were also examined, and the biochemical interaction between
PDI and SOD1 was determined by immunoprecipitation. In addition, the levels of S-nitrosylated PDI in cultured
astrocytes after oxygen glucose deprivation and reperfusion treatment were measured using the biotin-switch
assay. The formation of ubiquitinated-protein aggregates was detected by immunoblot and immunofluorescence
staining.
Results: Our data showed that the up-regulation of iNOS expression after oxygen glucose deprivation and
reperfusion treatment led to excessive NO generation. Up-regulation of PDI and SOD1 was also identified in
cultured astrocytes following oxygen glucose deprivation and reperfusion, and these two proteins were found to
bind to each other. Furthermore, the increased nitrosative stress due to ischemia/reperfusion injury was highly
associated with NO-induced S-nitrosylation of PDI, and this S-nitrosylation of PDI was correlated with the formation
of ubiquitinated-protein aggregates; the levels of S-nitrosylated PDI increased in parallel with the formation of
aggregates. When NO generation was pharmacologically inhibited by iNOS specific inhibitor 1400W, S-nitrosylation
of PDI was significantly blocked. In addition, the formation of ubiquitinated-protein aggregates in cultured
astrocytes following oxygen glucose deprivation and reperfusion was also suppressed by 1400W. Interestingly, these
aggregates were colocalized with SOD1, which was found to co-immunoprecipitate with PDI.
Conclusions: NO-mediated S-nitrosylation of PDI may be involved in the formation of the SOD1-linked
ubiquitinated-protein aggregates in cerebral ischemia/reperfusion injury.
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Background
Brain ischemia/reperfusion injury is a major public
health problem. It causes excitotoxicity, inflammation,
cell death, and compensatory neurogenesis [1,2]. Neu-
rons are more susceptible to hypoxic stress than astro-
cytes. They have fewer antioxidant mechanisms than
astrocytes and rely mainly on the metabolic support
from surrounding astrocytes [2–4]. It is proposed that
brain ischemia/reperfusion injury is a consequence of
the failure of astrocytes to support the essential needs of
neurons. Dysfunction of astrocytes may lead to increas-
ing neuronal death [2]. Any pathophysiological events
that affect the function of astrocytes would therefore
compromise their neuronal supportive role. One detri-
mental event after ischemia/reperfusion injury is the
dramatic increase in damaging free radicals, such as ni-
trogen oxide (NO), superoxide, and peroxynitrite [5].
Expressions and activities of nitrogen oxide synthases
(NOS) are enhanced in the experimental mouse model
of cerebral ischemia/reperfusion injury. Nitrogen oxide
and its further oxidative products are generally impli-
cated in the pathology of brain ischemia/reperfusion in-
jury. There are three isoforms of mammalian NOS:
neuronal NOS (nNOS), inducible NOS (iNOS), and
endothelial NOS (eNOS). Although experimental brain
ischemia/reperfusion injury leads to the up-regulation of
all three NOS isoforms, their expression patterns differ
both temporally and spatially. The induction of iNOS
expression occurs much later than nNOS and eNOS,
suggesting that iNOS contributes to relatively late injury
[6]. iNOS-deficient mice exhibit a significant reduction
in infarct volume and attendant behavioral change after
48 h of hypoxic or ischemic injury [7,8]. Studies show
that astrocytes are the cells mainly responsible for iNOS
expression after ischemia/reperfusion injury [9]. Once
iNOS is expressed following transient hypoxia or ische-
mia, it will promote the production of neurotoxic
amounts of NO [10,11], with maximal levels after 24 h
in the striatum and 48 h in the cortex, without any re-
quirement for further activation [12].
Ischemia/reperfusion injury may impair chaperone
function and ubiquitin-proteasomal degradation and
lead to protein aggregation [13]. Studies show that
ubiquitinated-protein aggregates can be visualized in
cultured astrocytes after glucose deprivation [14]. Ische-
mia/reperfusion injury disrupts proper peptide folding in
the endoplasmic reticulum (ER) and triggers ER stress
and an unfolded protein response [15]. The formation of
these ubiquitinated-protein aggregates is one of the con-
sequences of functional disturbance within the ER. The
proper maturation and folding of native proteins rely
on the activity of the ER chaperones and enzymes.
Dysfunction of ER chaperone proteins can lead to pro-
tein misfolding and further aggregation, which will be
recognized and ubiquitinated by the ubiquitin system
through a series of ATP-dependent reactions [16]. Pro-
tein disulfide isomerase (PDI), an ER chaperone, is crit-
ical for proper protein folding in the ER. Protein
disulfide isomerase is responsible for facilitating disulfide
bond formation, rearrangement reactions, and structural
stability [17]. Copper-zinc superoxide dismutase (SOD1)
is an intracellular homodimeric metalloprotein, which is
stabilized by an intrasubunit disulfide bond between
cysteine 57 and cysteine 146. Mutations in SOD1 protein
promote the formation of disulfide-reduced monomers,
which are prone to forming aggregates. Hence, modula-
tion of disulfide bond formation may be important in
SOD1-linked aggregate formation. Protein disulfide
isomerase was found to be associated with SOD1 in cel-
lular and animal models of familial amyotrophic lateral
sclerosis, a neurodegenerative disease affecting motor
neurons. Furthermore, a biochemical interaction be-
tween PDI and SOD1 is implicated in the pathogenesis
of familial amyotrophic lateral sclerosis [18]. In many
neurodegenerative disorders and cerebral ischemia, up-
regulation of PDI expression represents an adaptive re-
sponse that promotes protein refolding and may offer
neuronal cell protection [19,20]. Recently, Uehara and
colleagues [21] demonstrated that in Parkinson’s disease
and related neurodegenerative disorders, the NO-
mediated S-nitrosylation of PDI inhibits PDI function,
which leads to dysregulated protein folding, and conse-
quently results in ER stress that promotes neuronal cell
death. S-nitrosylation is an important biological reaction
of NO and involves the covalent addition of NO to a
cysteine thiol group of the protein to form S-nitro-
sothiols. This modification can affect many cellular pro-
cesses and alter both protein function and protein-
protein interactions [22].
In this study, we examined whether iNOS expression
was correlated with NO-induced S-nitrosylation of
PDI in cultured astrocytes following oxygen glucose
deprivation (OGD)/reperfusion treatment. We also
detected whether or not S-nitrosylation of PDI was
associated with an accumulation of ubiquitinated-protein
aggregates. We report here that the OGD/reperfusion
treatment of cultured astrocytes led to an increase in NO
production that was accompanied by augmented iNOS
protein expression. The expression of both PDI and
SOD1 were adaptively up-regulated in response to ische-
mia/reperfusion injury and an interaction between these
two proteins was identified in cultured astrocytes by using
co-immunoprecipitation. Although total PDI expression
was increased following OGD/reperfusion treatment, PDI
was found to be S-nitrosylated by ischemia/reperfusion-
induced nitrosative stress. The formation of S-nitrosylated
PDI (SNO-PDI) was detected in cultured astrocytes
following OGD/reperfusion treatment, and the SNO-PDI
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level had a parallel relationship with the formation of
ubiquitinated-protein aggregates. These aggregates were
found to be colocalized with SOD1 protein, which was
indicated to be a ubiquitinated protein in astrocytes under
ischemia/reperfusion stress. Blocking NO generation with
iNOS inhibitor 1400W significantly attenuated the forma-
tion of SNO-PDI and ubiquitinated-protein aggregates in
cultured astrocytes following OGD/reperfusion treatment.
We report here that, in cultured astrocytes, the up-
regulation of iNOS after OGD/reperfusion promoted the
NO-mediated S-nitrosylation of PDI. This modification of
PDI may affect the chaperone activity of PDI and result in
the formation of SOD1-linked ubiquitinated-protein
aggregates in cultured astrocytes.
Materials and methods
Primary astrocyte cell culture
Primary astrocytes were taken from cerebral cortices of
neonatal Wistar rats, as described previously [23]. Corti-
ces were harvested, while the meninges and blood ves-
sels were removed. Tissues were digested in 0.25%
trypsin containing 0.1 M EDTA at 37°C for 15 min, and
passed through a nylon sieve (80 μm pore size). The
cells were seeded in Dulbecco’s modified Eagle’s medium
supplemented with heat-inactivated 10% fetal calf serum,
50 μg/ml penicillin, and 100 μg/ml streptomycin. Cul-
tured cells were grown at 37°C in a humidified atmos-
phere with 5% CO2. After 10 days, the microglia and
oligodendrocyte progenitors were depleted by shaking.
The remaining astrocytes were then detached by trypsi-
nization and re-plated at a density of approximately 1 ×
105 cells/ml for future experiments. The purity of astro-
cytes (>90%) was identified by immunohistochemical
analysis with anti-glial fibrillary acidic protein.
OGD/reperfusion and 1400W treatment
On the third day of subculture, astrocytes were sub-
jected to OGD with Earl’s balanced salt solution (EBSS)
(6,800 mg/l NaCl, 400 mg/l KCl, 264 mg/l CaCl2·2H2O,
200 mg/l MgCl2·7H2O, 2,200 mg/l NaHCO3, 140 mg/l
NaH2PO4·H2O, pH 7.2) and incubated in a hypoxic in-
cubator filled with 1.5% O2 and 5% CO2 for 8 h. The
oxygen level in the OGD solution decreased to about 2%
to 3% after 60 min in the hypoxic incubator [24]. The
cells were then provided with a normal amount of oxy-
gen and maintenance medium without glutamate to
mimic in vivo reperfusion for up to 24 h. Normoxic con-
trol cells were incubated in 37°C with 5% CO2 and at-
mospheric air in a buffer almost identical to EBSS
except containing 5.5 mM glucose. iNOS inhibitor
1400W was prepared as a concentrated stock solution
according to the manufacturer’s instructions. The final
concentrations of 1400W in media applied to astrocytes
were: 1, 10, and 50 μM. 1400W was added to culture
medium 30 min prior to OGD exposure, and astrocytes
were maintained in EBSS and maintenance medium dur-
ing the treatment.
Measurement of NO level
The concentration of NO in the culture medium was
determined by the Griess reaction with minor changes
[25]. Briefly, 40 μl cell culture fluid, 10 μl NADPH, and
40 μl basal solution (0.03 M PBS; 1.25 mM glucose-6-
phosphate; 400 U/l glucose-6-phosphate dehydrogenase;
200 U/l nitrate reductase) were incubated in a 96-well
microtiter plate for 45 min at room temperature. Next,
50 μl Griess reagent was added and the solution incu-
bated for 20 min in the dark at room temperature. Fi-
nally, the absorbance of the samples was measured at
540 nm. NO2 concentrations were calculated from a
standard curve of sodium nitrite (NaNO2).
Western blot
Protein concentrations of cell lysates were determined
by using the bicinchoninic acid (BCA) method (Pierce,
Rockford). Samples (20 μg) were loaded on 12% sodium
dodecyl sulphate polyacrylamide gel (SDS-PAGE) for
electrophoresis and then transferred to the PVDF mem-
brane. Membranes were blocked with 5% (w/v) milk in
TBS-T buffer (10 mM Tris–HCl; pH 7.5; 150 mM NaCl;
0.05% Tween-20) for 1 h and then incubated with pri-
mary antibodies for 16 h at 4°C; SOD1 (1:2000, Santa
Cruz Biotechnology), iNOS (1:1000, Santa Cruz Biotech-
nology), PDI (1:1000, Cedarlane). β-actin was used as an
internal control (1:2000, Santa Cruz Biotechnology).
Blots were washed in TBS-T buffer three times, probed
with HRP-conjugated goat anti-rabbit or goat anti-
mouse antibodies at 1:2500 for 1 h at room temperature,
and then developed using chemiluminescence reagents
(PerkinElmer). Quantification of band intensities was
performed by densitometric analysis using Quantity
One® 1-D analysis software (Bio-Rad).
Immunoprecipitation
Whole-cell lysates (200 μl) were incubated with 50 μl of
protein A-Sepharose CL-4B (Amersham Biosciences) for
30 min at 4°C with gentle rotation to remove IgG from
the sample. The beads were briefly spun down and pre-
cleared cell lysates transferred to fresh tubes. 30 μl of
50% (w/v) protein A-Sepharose CL-4B in Tris buffer (50
mm Tris–HCl; pH 7.5;0.02% (w/v) NaN3) and anti-
SOD1 or anti-PDI (1:750) antibodies were incubated
with 100 μl precleared cell lysates on a rotating wheel
overnight at 4°C. 20 μg of total protein was incubated
with the sepharose-antibody to capture the antibody-
binding protein complexes. After centrifugation at
15,800g for 1 min to remove the supernatant, the pre-
cipitate was washed three times in Tris buffer for 10
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min each time. Both the supernatant and the immuno-
precipitate was mixed with a 2% (w/v) SDS sample load-
ing buffer and used for SDS-PAGE and immunoblot,
following the methods described.
Biotin-switch assay for detection of SNO-PDI
The cell lysates were prepared in HENC buffers (250 mM
HEPES pH 7.5; 1 mM EDTA; 0.1 mM neocuproine; 0.4%
CHAPS). Typically 1 mg of cell lysate was used. The
blocking buffer (2.5% SDS, 20 mM methyl methane thio-
sulfonate (MMTS) in HEN buffer) was mixed with the
samples and incubated for 30 min at 50°C to block any
free thiol groups. After removing excess MMTS by acet-
one precipitation, nitrosothiols were reduced to thiols with
1 mM ascorbate. The newly formed thiols were then
linked with the sulfhydryl-specific biotinylating reagent N-
(6-(biotinamido)hexyl)-30-(20-pyridyldithio)propionamide
(biotin-HPDP). The biotinylated proteins were pulled
down with streptavidin-agarose beads. Western blot ana-
lysis was then performed to detect the amount of PDI
remaining in the samples [26].
Subcellular fractionation
Both the pellet and cytosolic fraction were prepared as
described by Chen et al. [27]. Briefly, cell lysates of cul-
tured astrocytes were sonicated for 30 s at 4°C in ice-
cold lysis buffer (pH 7.6) containing: 15 mM Tris–HCl,
1 mM dithiothreitol, 250 mM sucrose, 1 mM MgCl2, 2.5
mM EDTA, 1 mM EGTA, 250 mM Na3VO4, 25 mM
NaF, 2 mM sodium pyrophosphate, 0.5 mM phenyl-
methylsulfonyl fluoride, plus 1 μg/ml pepstatin A, 5 μg/
ml leupeptin, and 2.5 μg/ml aproptonin. The protein
content of the lysates was determined by BCA assay.
Equal amounts of total cell lysate protein in each sample
(0.5 mg) were centrifuged at 13,000g in 4°C for 10 min.
The pellet fractions were sonicated three times and
washed for 1 h at 4°C with 2% Triton X-100 and 150
mM KCl in the ice-cold lysis buffer. After being centri-
fuged at 13,000g in 4°C for 10 min, the pellet fraction
containing the detergent and salt-insoluble aggregates
was sonicated and redissolved in the lysis buffer for
Western blotting.
Double-immunofluorescence staining of ubiquitin and
SOD1
Astrocytes on coverslips were fixed with 4% paraformal-
dehyde in PBS for 20 min. After being rinsed three
times, cells were incubated with the blocking buffer (5%
goat serum, 0.3% Triton X-100, and 1% bovine serum al-
bumin in PBS) for 1 h, the coverslips were incubated
with primary antibodies against ubiquitin (1:500) and
SOD1 (1:1000) overnight at 4°C. After rinsing, coverslips
were incubated with Alexa Fluor 488 anti-mouse IgG or
594 anti-rabbit IgG for 1 h at 37°C. Then Hoechst 33342
was added to stain the nuclei and the coverslips were
mounted on the slides. The slides were imaged by an ob-
server blind to treatments on a Zeiss Axiovert upright
fluorescent microscope with identical exposure settings
and identical post-acquisition processing for each image.
Statistical analysis
Quantification of band intensities was performed by
densitometric analysis using Quantity One® 1-D analysis
software (Bio-Rad). The statistical calculations and
graphing were performed using GraphPad Prism® soft-
ware, version 5. All data were tested using one-way ana-
lysis of variance (ANOVA) with Tukey’s post-hoc test. A
P value of 0.05 or less was judged significant. Results
were expressed as mean ± SEM.
Results
OGD/reperfusion induces NO formation and iNOS protein
expression
The cortical astrocyte culture was subjected to OGD for
8 h and then exposed to reperfusion for either 16 h or
24 h. The concentration of NO in the culture media and
the protein expression of iNOS were then determined.
Nitrogen oxide generation was slightly increased after
OGD treatment. The increase of NO was exaggerated by
the reperfusion treatment. The concentration of NO
reached a maximal level at the latest time studied (OGD
8 h/reperfusion 24 h) (Figure 1A). A similar result was
observed in the iNOS protein assay. Under normal cir-
cumstances, the iNOS expression was too low to be
detected. After OGD treatment, the iNOS expression
was up-regulated. The reperfusion treatment led to a
dramatic increase of iNOS expression in reactive astro-
cytes compared with the control cells that were not trea-
ted. When iNOS protein expression was quantified,
exposure to OGD/reperfusion induced a remarkable in-
crease in the iNOS protein level, especially in astrocytes
following OGD 8 h/reperfusion 24 h. These cells exhib-
ited a significant increase of iNOS expression, about 2.5-
fold as compared with the control (Figure 1B).
PDI and SOD1 are up-regulated after OGD/reperfusion
treatment, and they were binding to each other
We investigated the changes in PDI and SOD1 expres-
sion levels following OGD/reperfusion treatment in cul-
tured astrocytes. Cell lysates from astrocytes under
various treatments were analyzed by immunoblot. Western
blot analysis using anti-PDI monoclonal antibody revealed
an enhancement of PDI expression after OGD at 8 h,
and this had reached a maximum by 24 h of reperfu-
sion (Figure 2A). A similar pattern was also observed in
SOD1 expression. Immunoblot analyses confirmed an
increased expression of SOD1 in cultured astrocytes
when they were exposed to OGD for 8 h. In addition,
Chen et al. Journal of Neuroinflammation 2012, 9:237 Page 4 of 14
http://www.jneuroinflammation.com/content/9/1/237
reperfusion significantly induced appreciable SOD1 ex-
pression in these cells, yielding a three-fold higher
abundance of SOD1 protein in the OGD 8 h/reperfu-
sion 24 h group when compared with the control group
(Figure 2B). These results demonstrate that the eleva-
tion of PDI and SOD1 expression correlate well with
the induction of iNOS in activated astrocytes following
OGD/reperfusion treatment. We then used immuno-
precipitation to examine the interaction between PDI
and SOD1. Cell lysates from astrocytes under various
treatments were subjected to immunoprecipitation
using the anti-SOD1 antibody or anti-PDI antibodies.
Western blot analysis of immunoprecipitated proteins
revealed that PDI was co-precipitated by anti-SOD1
antibody and that SOD1 was co-precipitated by the
anti-PDI antibody. This result suggested a physical
interaction between PDI and SOD1. Fainter PDI bands
were observed in the OGD/reperfusion group after
immunoprecipitation using the anti-SOD1 antibody.
The up-regulated PDI after OGD/reperfusion treatment
seemed not to bind any more SOD1 in the immunopre-
cipitation studies. The reverse experiment was also
performed: the cell lysates were immunoprecipitated
with anti-PDI antibody, followed by Western blot with
anti-SOD1 antibody. The SOD1 bands were observed,
which were also more abundant in the control group
(Figure 2C).
PDI is S-nitrosylated in astrocytes following OGD/
reperfusion; this S-nitrosylation of PDI is blocked by iNOS
inhibitor 1400W
We investigated whether or not aberrant generation of
NO through activation of iNOS mediated S-nitrosylation
of PDI in reactive astrocytes following OGD/reperfusion.
Using a biotin-switch assay, we identified that PDI was
S-nitrosylated in cultured astrocytes after ischemia/
reperfusion injury. The specificity of the biotinylation re-
action was confirmed by no detection of SNO-PDI in
the samples without the presence of ascorbate. Ascor-


































































































Figure 1 Effect of OGD/reperfusion on NO production and iNOS expression. A. The changes of NO levels in cultured astrocytes following
OGD/reperfusion as determined by Griess reagent. Following reperfusion, NO production increased gradually and reached a peak under the
treatment of OGD 8 h/reperfusion 24 h. This increase was significant in comparison with all other groups. B. iNOS protein levels in cultured
astrocytes following OGD/reperfusion as determined by Western blotting. Full-length iNOS protein (~130 kDa) was more enriched in the OGD/
reperfusion groups compared with the control group. OGD/reperfusion significantly induced greater levels of iNOS than in normal conditions.
Five independent experiments were performed and data were analyzed in triplicate. Values were presented as mean ± SEM; *, P < 0.05;
**, P < 0.01; ***, P < 0.001 by one-way ANOVA (analysis of variance) with Tukey’s post-hoc test.
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of nitrosothiol groups required for reacting with the bio-
tinylating reagent biotin-HPDP [28]. In addition, no de-
tection of SNO-PDI in the absence of biotin-HPDP also
confirmed the specificity of the final streptavidin precipita-
tion step of the assay (Figure 3A). Despite the fact that
total PDI levels were increased in astrocytes under OGD/
reperfusion treatment, abundant SNO-PDI levels were
detected in astrocytes following OGD 8 h/reperfusion 24
h treatment. However, SNO-PDI was virtually undetect-
able in the control group and the OGD 8 h group. This
trend of SNO-PDI level was consistent with the change
of iNOS expression and NO level during the OGD/reper-
fusion process (Figure 3B). To rule out the possibility
that the detectable SNO-PDI in the OGD/reperfusion
group resulted from the up-regulation of total PDI expres-
sion after OGD/reperfusion treatment, we deliberately
increased total protein loading to enhance total PDI level
in the control group. However, we could not detect the
presence of SNO-PDI in the control group. Furthermore,
in the OGD 8 h/reperfusion 24 h group, with manipulated
less total PDI level owing to less total protein loading had
detectable SNO-PDI. These results demonstrate that NO-
mediated S-nitrosylation of PDI is a characteristic feature
of astrocytes in response to ischemia/reperfusion injury.
To determine whether iNOS plays a role in promoting the
SNO-PDI formation, we pretreated primary astrocytes
cultures with the iNOS inhibitor 1400W for 30 min








































































































Figure 2 Expression of PDI and SOD1 in cultured astrocytes following OGD/reperfusion. A. PDI expression in cultured astrocytes showed
an increasing trend in the process of reperfusion and peaked at OGD 8 h/reperfusion 24 h. B. SOD1 expression in cultured astrocytes increased
gradually during the process of OGD/reperfusion and reached a peak at OGD 8 h/reperfusion 24 h. C. The anti-SOD1 antibody co-precipitated
PDI, and the anti-PDI antibody co-precipitated SOD1 in cultured astrocytes. Three separate immunoprecipitations were performed, and data were
analyzed in triplicate. Data were presented as mean ± SEM; *, P < 0.05; **, P < 0.01; ***, P < 0.001 by one-way ANOVA (analysis of variance) with
Tukey’s post-hoc test.
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Figure 3 S-nitrosylation of PDI in astrocytes following OGD/reperfusion. A. In the presence of both ascorbate and biotin-HPDP, astrocytes
following OGD 8 h/reperfusion 24 h treatment had detectable SNO-PDI, indicating the specificity of biotin-switch assay. B. PDI was S-nitrosylated
in cultured astrocytes following OGD/reperfusion. Densitometric quantitation showed significant differences of SNO-PDI levels between the
control group and the OGD/reperfusion groups. C. 1400W significantly inhibited NO production; the iNOS protein expression remained unaltered
in cultured astrocytes following OGD 8 h/reperfusion 24 h. The cultured astrocytes were pretreated with various concentrations of iNOS inhibitor
1400W, which suppressed the S-nitrosylated PDI formation under OGD 8 h/reperfusion 24 h. The level of SNO-PDI was reduced with the
increased concentration of 1400W (1, 10, and 50 μM). Moreover, 1400W suppressed S-nitrosylation of PDI, with the maximum effect seen at the
concentration of 50 μM. Three independent experiments were performed. Data were presented as mean ± SEM; *, P < 0.05; **, P < 0.01; ***,
P < 0.001 by one-way ANOVA (analysis of variance) with Tukey’s post-hoc test.
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pretreatment strongly inhibited iNOS activity as demon-
strated by dose-dependent suppression of NO production
in reactive astrocytes. However, the iNOS protein levels
were not affected by 1400W (Figure 3C). Immunoblot
analysis of cell lysates revealed that NO-mediated SNO-
PDI formation following OGD/reperfusion treatment in
astrocytes was significantly blocked by iNOS inhibition,
with the blockade behaving in a dose-dependent manner.
These results suggest that iNOS signaling is involved in
the SNO-PDI formation in astrocytes following OGD/
reperfusion (Figure 3).
OGD/reperfusion triggers formation of detergent/
salt-insoluble ubiquitinated-protein aggregates, which
is blocked by iNOS inhibitor 1400W
Protein aggregates have low solubility in the detergent/salt
solution. We examined the formation of detergent/salt-in-
soluble ubiquitinated-protein aggregates in astrocytes
under normoxic control conditions and after exposure
to OGD/reperfusion. Under normal control conditions,
the pellet fraction of astrocytes showed no or hardly any
detectable ubiquitinated-protein aggregates. In contrast,
during OGD/reperfusion treatment, there was a time-
dependent accumulation of ubiquitinated proteins in the
pellets. The ubiquitinated-protein smears ranged between
37 and 250 kDa, as detected by a monoclonal anti-
ubiquitin antibody. Since these proteins were detergent/
salt-insoluble, they were considered to be protein aggre-
gates (Figure 4A). OGD led to a slight increase in
ubiquitinated-protein aggregate formation. However, the
difference between the OGD 8 h group and the control
group did not reach statistical significance. The level of
ubiquitinated-protein aggregates was further developed
and reached approximately six-fold at 16 h reperfusion; it
remained significantly elevated at 24 h reperfusion, at
which point it was about eight-fold as compared with the
OGD 8 h group (Figure 4B). These results suggest that
OGD/reperfusion results in a progressive formation of
ubiquitinated-protein aggregates. These aggregates may
link to the formation of SNO-PDI in astrocytes. Since
inhibiting the activity of iNOS through inhibitor 1400W
led to the suppression of S-nitrosylation of PDI, we
hypothesized that while S-nitrosylation of PDI was
blocked by 1400W, the formation of ubiquitinated-protein
aggregates might be subsequently inhibited. We examined
the changes of ubiquitinated-protein aggregate levels in
astrocytes following OGD 8 h/reperfusion 24 h treatment
when S-nitrosylation of PDI was inhibited by 1400W. In
the presence of various concentrations of 1400W, the
levels of ubiquitinated-protein aggregates were signifi-
cantly decreased in a dose-dependent manner. This
change of ubiquitinated-protein aggregates with the use of
1400W correlated well with the change of SNO-PDI for-
mation (Figure 4).
OGD/reperfusion induces redistribution of ubiquitinated
protein, and colocalization of ubiquitin with SOD1 protein
Since the monoclonal anti-ubiquitin antibody can
recognize both free and conjugated ubiquitin, it was
used to monitor both ubiquitin redistribution and for-
mation. The normoxic control astrocytes showed even
and diffuse immunoreactivity of ubiquitin with nuclear
staining. In astrocytes subjected to OGD 8 h/reperfusion
16 h treatment, the diffuse distribution of free ubiquitin
was absent; instead, the ubiquitin immunoreactivity
changed into loss of nuclear staining and the appearance
of aggregates throughout the cytoplasm. This punctu-
ated ubiquitin in the perinuclear regions were consid-
ered to be the conjugated ubiquitin. With the use of
1400W to inhibit the S-nitrosylation of PDI, the punctu-
ated staining of ubiquitin in the cytoplasm was less
abundant when compared with those cells without
1400W treatment (Figure 5A). To investigate whether
this ubiquitin was conjugated to SOD1 protein, we
examined the localization of SOD1 under normal condi-
tions and under conditions of OGD/reperfusion. Under
normal conditions, SOD1 was distributed in the nucleus
and throughout the cytosol. However, following OGD 8
h/reperfusion 16 h, the SOD1 immunoreactivity was
clustered near nuclei in addition to the nuclear distribu-
tion. Small SOD1-positive aggregates were seen in the
cytoplasm of astrocytes following OGD 8 h/reperfusion
16 h. To further examine the ubiquitination of SOD1,
we performed double immunostaining with anti-SOD1
and anti-ubiquitin antibodies. After OGD 8 h/reperfu-
sion 16 h treatment, the cultured astrocytes were immu-
nostained with anti-SOD1 and anti-ubiquitin antibodies
(Figure 5B). As a result, SOD1 aggregates induced by
OGD 8 h/reperfusion 16 h were clearly colocalized with
ubiquitin, indicating the ubiquitination of the SOD1 pro-
tein (Figure 5).
Discussion
Brain ischemia/reperfusion injury encompasses all cell
types in the central nervous system, including neurons
and astrocytes. Astrocytes are believed to play a funda-
mental role in the pathogenesis of neuronal death. The
failure of astrocytes in supporting the essential needs of
neurons constitutes a great threat for neuronal survival.
The multifaceted and complex role of astrocytes in re-
sponse to injury includes the enhancement of neuronal
survival or regeneration and contributes to further injury
[29,30]. Glial cells, including astrocytes, generate exces-
sive amounts of NO as a result of the activation of
iNOS, and NO can induce neuronal apoptosis in ische-
mia/reperfusion injury. However, the cellular and mo-
lecular mechanisms of neuronal death induced by
excessive NO have not yet been clearly defined. Brain
hypoxic or ischemic injury is associated with an obvious
















































































































Figure 4 Formation of detergent/salt-insoluble ubiquitinated-protein aggregates following OGD/reperfusion, and the inhibition of
1400W. A. Protein smears ranging from 37 to 250 kDa were considered to be of ubiquitinated proteins. Increased levels of detergent/salt-
insoluble ubiquitinated-protein aggregates were observed in pellet fractions under OGD/reperfusion. This change was more pronounced in OGD
8 h/reperfusion 24 h group. 1400W inhibited the formation of ubiquitinated-protein aggregates in the insoluble pellet fraction, with the
maximum effect seen at the concentration of 50 μM. B. The ubiquitinated-protein aggregates were quantified using average intensity of protein
smear, using β-actin as an internal control. Data from three independent experiments were presented as mean ± SEM; *, P < 0.05; **, P < 0.01;
***, P < 0.001 by one-way ANOVA (analysis of variance) with Tukey’s post-hoc test.
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inflammatory reaction that results in the expression and
release of several cytokines [31]. These important media-
tors activate the expression of iNOS in different cell
types, including glial cells in the central nervous system
[32–34]. Interleukin-1β and tumor necrosis factor are
both significantly increased within a few hours of ische-
mia. Interleukin-1β and tumor necrosis factor trigger
transcriptional activation of the iNOS gene and then
up-regulate iNOS expression [35,36]. Oxidative stress
induced by ischemia might itself trigger the induction of
iNOS. Moreover, the iNOS promoter contains a hypoxia
response element, since a specific pathway, the hypoxia-
inducible factor-1α pathway, can be activated at the onset
of ischemia [37]. Consequently, the generation of NO per-
sists. It is believed that NO produced by de novo expres-
sion of iNOS contributes to brain damage caused by
hypoxic ischemia [38]. In the present study, we examined
whether iNOS expression was enhanced in response to
OGD/reperfusion in astrocytes. Consistently with previous
research, OGD/reperfusion markedly elevated iNOS pro-
tein levels in cultured astrocytes. Our study gives the first
demonstration that PDI is S-nitrosylated in cultured astro-
cytes following ischemia/reperfusion injury, and that
this is highly associated with extensive generation of
NO, which is induced by up-regulated iNOS expres-
sion. This finding suggests that S-nitrosylation of PDI
probably inactivates the normal properties of PDI, and
that it may contribute to the pathogenesis of ischemia/
reperfusion injury.
Protein disulfide isomerase is a ubiquitous, highly
conserved redox enzyme from the thioredoxin super-
family, located mainly in the ER [39]. During protein
folding in the ER, PDI facilitates proper protein folding
and helps to maintain the structural stability of the ma-
ture protein [17]. As a consequence, PDI is considered
to be a molecular chaperone capable of stabilizing the
correct folding of substrate proteins. It also facilitates
the ER-associated degradation of misfolded proteins
[40]. Protein disulfide isomerase is involved in the retro-
translocation of misfolded cholera toxin from the ER to
the cytoplasm by interacting with the ER transmem-
brane protein Derlin-1 [41]. In this study, we found that
PDI expression was up-regulated in astrocytes following
OGD/reperfusion. This result was consistent with previ-
ous studies that have demonstrated the up-regulation of
PDI in astrocytes in response to hypoxia or transient
forebrain ischemia in astrocytes [42]. A study of ische-
mic cardiomyopathy indicates that PDI is up-regulated
Control OGD 8h/reperfusion 16h
Control Control Control
Ubiquitin                     SOD1                              Merge





Figure 5 Distribution of ubiquitin-conjugated proteins and SOD1 in cultured astrocytes following OGD/reperfusion. A. In astrocytes, the
ubiquitin immunoreactivity in the normoxic control group was evenly distributed in cytoplasm and nucleus. Following OGD 8 h/reperfusion 16 h,
the diffused distribution of free ubiquitin lost nuclear staining and clustered immunoreactivity appeared near the nucleus. 1400W attenuated the
punctuated ubiquitin perinuclear distribution B. Colocalization of ubiquitin and SOD1. Following OGD 8 h/reperfusion 16 h, were identified. SOD1
immunoreactivity colocalized with ubiquitinated-protein aggregates and showed a pattern of punctuated perinuclear-nuclear localization. Scale
bar, 100 μm; green, ubiquitin immunosignals; red, SOD1 immunosignals; blue, nucleus staining with Hoechst 33342.
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in the viable peri-infarct myocardial region after infarc-
tion. This up-regulation of PDI led to a significant de-
crease in the rate of cardiomyocyte apoptosis [43]. All of
this evidence put together indicates that the up-
regulation of PDI in ischemia/reperfusion injury repre-
sents an adaptive response that promotes correct protein
folding and offers potential protection to cells. However,
detrimental generation of NO derived from iNOS
induces S-nitrosylation of PDI; this posttranslational
modification of PDI may attenuate its protective effects
in ischemia/reperfusion injury.
As we know, ischemia-reperfusion causes accumula-
tion of high-molecular weight ubiquitinated proteins fol-
lowing forebrain ischemia [44]. These ubiquitinated-
protein aggregates are visualized in cultured astrocytes
following glucose deprivation/recovery [14]. They are
clustered with co-translational chaperones, protein fold-
ing enzymes [45], subcellular structures [46], protea-
somes [47], and stress granules [48]. These changes may
contribute to ischemic dysfunction of astrocytes and lead
to neuronal damage. The accumulation of misfolded
protein in the ER results in ER stress that triggers the
protective unfolded protein response. The unfolded pro-
tein response entails the induction of chaperone mole-
cules, the degradation of misfolded proteins, and the
inhibition of protein translation [49]. Nonetheless, pro-
longed ER stress can still lead to activation of apoptosis
[50]. Studies on pancreatic β cells, macrophages [51],
and cerebellar granule cells [52] have demonstrated that
NO can also induce ER stress. However, the molecular
basis of this remains unknown. Furthermore, although
the involvement of NO in the pathology of brain ische-
mia/reperfusion injury has been widely accepted, the
chemical relationship between nitrosative stress and for-
mation of ubiquitinated-protein aggregates has remained
obscure. Our findings indicate that S-nitrosylation of
PDI may hold some of the answers to these questions.
Studies have shown that in Parkinson’s disease, excito-
toxic activation of nNOS leads to excessive NO gener-
ation, which causes S-nitrosylation of the active-site
thiols of PDI and inhibits its corresponding isomerase
and chaperone activities [21]. In this way, NO blocks the
protein’s protective effects via S-nitrosylation of PDI. S-
nitrosylation of PDI leads to the accumulation of mis-
folded and polyubiquitinated proteins, and results in
prolonged unfolded protein response activation. NO-
mediated S-nitrosylation of PDI, therefore, participates in
persistent ER stress and the induction of apoptosis [21].
We further demonstrated that NO-mediated S-nitro-
sylation of PDI may take part in the formation of
ubiquitinated-protein aggregates in cultured astrocytes
following OGD/reperfusion, since the aggregate’s forma-
tion was blocked by the iNOS inhibitor 1400W, which
could efficiently inhibit the S-nitrosylation of PDI.
When cultured astrocytes were subjected to OGD/reper-
fusion, the cells formed smear detergent/salt-insoluble
ubiquitinated-protein aggregates. Furthermore, diffuse
free ubiquitin staining changed into punctuated staining
within perinuclear regions. This conjugated ubiquitin
with reduced cytosolic and nuclear free ubiquitin distri-
bution was considered to be an ubiquitinated-protein ag-
gregate. The formation of these aggregates correlated
well with the level of S-nitrosylation of PDI. With the
use of 1400W to inhibit the activity of iNOS, the gener-
ation of NO was consequently decreased, which subse-
quently led to down-regulation of SNO-PDI levels. With
the inhibition of S-nitrosylation of PDI, the formation of
ubiquitinated-protein aggregates was decreased, since
the detergent/salt-insoluble smear of ubiquitin in the
pellet fraction was significantly reduced through the
use of 1400W. This finding clearly demonstrates that
blocking NO generation reduces the accumulation of
ubiquitinated-protein aggregates. This blockade effect
of 1400W may, result from reducing NO-mediated S-
nitrosylation of PDI.
Free radicals contribute to neuronal death following
hypoxic/ischemic brain injury. Not surprisingly, several
studies have demonstrated that antioxidant treatment
improves neuroprotection and recovery after brain in-
jury [53–55]. SOD1 is an enzyme that detoxifies free
radicals under normal physiologic conditions. SOD1
converts the superoxide anion into hydrogen peroxide,
which is subsequently detoxified to water by glutathione
peroxidase or catalase [56]. Reperfusion following cere-
bral ischemia leads to an overproduction of free radicals
and the consumption of endogenous antioxidants. Neu-
rons are particularly vulnerable to free radical damage,
partly because of their relatively low levels of endogen-
ous antioxidants. Studies have shown that non-neuronal
cells may participate in free radical scavenging during is-
chemia/reperfusion [57]. One facet of reactive astrocytes
in brain ischemia/reperfusion injury is the chronic secre-
tion of antioxidants for neuronal protection and survival.
SOD1 is one of the beneficial antioxidants produced by
astrocytes. Prior studies using transgenic animal models
have clearly established a beneficial role of SOD1 in
adult ischemia/reperfusion injury [58]. Rodents overex-
pressing SOD1 have a much better outcome following
head injury [59]. In our study, the expression of SOD1
was up-regulated in cultured astrocytes following OGD/
reperfusion. The increased expression of SOD1 may rep-
resent a protective response to ischemic stress that
enhances the antioxidant ability. However, studies have
shown that SOD1 overexpression offers no protection
under OGD conditions in a hippocampal culture model
of excitotoxic injury [60]. Our results regarding the S-
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nitrosylation of PDI in cultured astrocytes following
OGD/reperfusion provides an explanation to this find-
ing. First, SOD1 was shown to be one of the PDI mo-
lecular targets [61] in ischemic cardiomyopathy. Second,
a physical interaction between SOD1 and PDI has been
indicated in cultured cells in familial amyotrophic lateral
sclerosis [18]. Protein disulfide isomerase binds to both
wild-type and mutant SOD1, and colocalizes with intra-
cellular aggregates of mutant SOD1. Inhibition of the ac-
tivity of PDI with the use of bacitracin increases
aggregate production [18]. In patients with amyotrophic
lateral sclerosis, PDI was found to be colocalized with
SOD1 in neuronal cytoplasmic inclusions [62]. In this
study, PDI and SOD1 were found to bind to one another
in astrocyte cultures. Although PDI was up-regulated
after OGD/reperfusion treatment, the increased total
PDI did not bind more SOD1. Instead, less PDI-SOD1
binding was detected after OGD/reperfusion treatment
in immunoprecipitation. It is possible that, despite the
induction of PDI after ischemia/reperfusion injury, the
SNO-PDI could not bind to SOD1 as efficiently as a nor-
mal PDI. In addition, SOD1 was ubiquitinated to form
aggregates, and the insoluble SOD1 aggregates could not
be detected in the soluble cell lysates used in the experi-
ment. Some proportion of PDI was associated with
SOD1 aggregates in the insoluble fraction of the cell
lysates. We may suppose that PDI normally binds to
SOD1 to form a disulfide-linked dimer. However, if PDI
were S-nitrosylated, it could not bind to SOD1 as effi-
ciently; and the disulfide-reduced SOD1 would more
easily form aggregates. The diffuse distribution of SOD1
within the cytosol and nucleus under normal conditions
changed into punctuated perinuclear and nuclear distri-
bution following treatment with OGD 8 h/reperfusion
16 h. This result suggests abnormal folding of SOD1 in
the cytoplasm had occurred. The ubiquitin-proteasome
system (UPS) is the major intracellular proteolytic mech-
anism that controls the degradation of misfolded or ab-
normal proteins [63]. The colocalization of SOD1 and
ubiquitin indicates that the misfolded SOD1 is ubiquiti-
nated for further degradation.
Conclusions
In this study, we have successfully demonstrated for the
first time that OGD/reperfusion treatment in cultured
astrocytes leads to an excess amount of NO generation
by iNOS up-regulation in response to stress induced by
ischemia/reperfusion. This leads to the formation of
ubiquitinated-protein aggregates, probably through the
process of S-nitrosylation of PDI. Our elucidation of an
NO-mediated pathway that causes dysfunction of PDI by
S-nitrosylation provides a mechanistic link between free
radical production and abnormal protein aggregation in
brain ischemia/reperfusion-induced injury. NO-based
therapeutic strategies may help prevent aberrant protein
misfolding by targeting the disruption or prevention of
nitrosylation of specific proteins such as PDI. These
therapeutic strategies may help improve the protective
astrocytic activities in the future, thus enhancing neur-
onal survival, and improving the outcomes following
brain ischemia/reperfusion injury.
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